• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Syncona

parasailing over clouds in Salzburg Austria
Biotech

Recursion refreshes leadership with CEO swap—Chutes & Ladders

Recursion refreshes leadership team with CEO swap. Ratio nabs Novartis vet as strategy chief. Draig looks to soar with new neuro CEO.
Darren Incorvaia , Zoey Becker Nov 7, 2025 8:30am
red and purple piggy banks

Syncona cites 'challenging' market for switching investment plan

Jun 20, 2025 6:00am
Paraglider over Lake Tahoe

Weight of market pressures pushes Novo CEO out—Chutes & Ladders

May 23, 2025 8:30am
pay deal hand over cash licensing transaction money

Syncona adds two cancer biotechs to growing portfolio

Jun 20, 2024 8:37am
MA

Syncona merges Freeline, SwanBio into new gene therapy biotech

Jun 17, 2024 11:01am
Lifeline

Syncona throws lifeline to Freeline by buying struggling biotech

Nov 22, 2023 9:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings